Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial. Rice, Simon M., Hickie, Ian B., Yung, Alison R., Mackinnon, Andrew, Berk, Michael, Davey, Christopher, Hermens, Daniel F., Hetrick, Sarah E., Parker, Alexandra G., Schäfer, Miriam R., McGorry, Patrick D. and Amminger, G. Paul 2016, Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial., Early intervention in psychiatry, vol. 10, no. 4, pp. 290-299, doi: 10.1111/eip.12166. Attached Files Name Description MIMEType Size Downloads Title Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial. Author(s) Rice, Simon M. Hickie, Ian B. Yung, Alison R. Mackinnon, Andrew Berk, Michael orcid.org/0000-0002-5554-6946 Davey, Christopher Hermens, Daniel F. Hetrick, Sarah E. Parker, Alexandra G. Schäfer, Miriam R. McGorry, Patrick D. Amminger, G. Paul Journal name Early intervention in psychiatry Volume number 10 Issue number 4 Start page 290 End page 299 Total pages 10 Publisher Wiley Place of publication London, Eng. Publication date 2016-08 ISSN 1751-7893 Keyword(s) adolescent major depressive disorder omega-3 fatty acid randomized control trial young adult Summary US authorities have recommended 'black-box' warnings for antidepressants because of the increased risk of suicidality for individuals up to age 25. There is thus a clinical and ethical imperative to provide effective treatment for youth depression with an acceptable risk-benefit balance. Long-chain omega-3 polyunsaturated fatty acids (PUFAs) play an important role in a range of physiological processes in living organisms. Supplementation with omega-3 PUFAs has been shown to have a range of beneficial effects on both physical and mental health, and results of previous trials suggest that omega-3 PUFAs may be a safe and effective treatment for depression. However, conclusions from these trials have been limited by their relatively small sample sizes. Language eng DOI 10.1111/eip.12166 Field of Research 119999 Medical and Health Sciences not elsewhere classified Socio Economic Objective 920410 Mental Health HERDC Research category C1 Refereed article in a scholarly journal ERA Research output type C Journal article Copyright notice ©2016, Wiley Persistent URL http://hdl.handle.net/10536/DRO/DU:30067213 Document type: Journal Article Collections: Faculty of Health School of Medicine Related Links Link Description Connect to published version Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Versions Version Filter Type Tue, 04 Nov 2014, 10:34:13 EST Mon, 08 Dec 2014, 10:58:31 EST Mon, 08 Dec 2014, 11:11:01 EST Mon, 08 Dec 2014, 11:20:32 EST Thu, 11 Dec 2014, 08:27:07 EST Thu, 11 Dec 2014, 08:28:14 EST Tue, 14 Apr 2015, 09:12:59 EST Tue, 26 Jul 2016, 09:43:39 EST Tue, 26 Jul 2016, 09:45:21 EST Tue, 15 Nov 2016, 09:41:18 EST Fri, 09 Dec 2016, 13:54:07 EST Fri, 21 Apr 2017, 07:01:52 EST Filtered Full Citation counts:   Cited 9 times in TR Web of Science Cited 1 times in Scopus Search Google Scholar Access Statistics: 606 Abstract Views, 3 File Downloads  -  Detailed Statistics Created: Mon, 08 Dec 2014, 10:58:31 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.